Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
2
×
Tags
biotech
clinical trials
glaxosmithkline
life sciences
national blog main
2
×
new york blog main
2
×
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san francisco blog main
san francisco top stories
abbvie
acute migrane
aimmune therapeutics
akcea therapeutics
akebia therapeutics
alex pinto
amarin pharma
amarna therapeutics
amylyx
amyotrophic lateral sclerosis (als)
anemia
antibody drug
bain capital
bausch health
biofourmis
boston blog main
boston pharmaceuticals
boston top stories
boulder/denver blog main
boulder/denver top stories
breast cancer
cancer immunotherapy
casdin capital
chronic kidney disease
clene nanomedicine
corvex management
covid-19
cystic fibrosis
desmoid tumor
What
days
summer
abbvie’s
activity
ahead
bio
biofourmis
biotech
bucks
cancer
celebrate
chance
companies
corner
day
dog
drug
firm
forward
hasn’t
holiday
ipo
ipos
labor
leading
line
looking
migraine
people
pfizer
pharma
place
prep
roundup
satsuma
securing
slowed
spinout
springworks
stopped
Language
unset
Current search:
summer���s
×
photo
×
" national blog main "
×
" new york blog main "
×
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
4 years ago
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs